-
CompareTheraPEAK® 4D-Nucleofector® LV Reservoirs, weldable (5 pcs)Catalog #: G4LR-1501WFor use in combination with TheraPEAK® Nucleocuvette® Cartridges, supporting the use of the 4D-Nucleofector® LV Unit in a GMP environment.Sales unit: items
-
CompareTheraPEAK® P3 Primary Cell Nucleofector® Solution Set (22.5 mL + 5 mL)Catalog #: G4LP3-22500
For use in combination with TheraPEAK® Nucleocuvette® Cartridges, supporting the use of the 4D-Nucleofector® LV Unit in a GMP environment.
Sales unit: items -
CompareHuman Peripheral Blood Mononuclear Cells (hPBMC), Cryopreserved, 100 million, with cell population frequencyCatalog #: CC-2703P
Cryopreserved ampule of Human Peripheral Blood Mononuclear Cells (hPBMC) containing ≥ 100 million cells with cell population frequency information
Sales unit: Ampule -
CompareHuman Bone Marrow CD34+ Progenitor Cells, Cryopreserved, 100,000Catalog #: 2M-101
Bone Marrow CD34+ Cells, 100,000 cells, cryopreserved, positively selected
Sales unit: each -
CompareHuman Bone Marrow CD34+ Progenitor Cells, Cryopreserved, 1 MillionCatalog #: 2M-101CBone Marrow CD34+ Cells, 1 Million, Cryopreserved, Positively SelectedSales unit: each
-
CompareHuman Bone Marrow CD34+ Progenitor Cells, Cryopreserved, 500,000Catalog #: 2M-101B
Bone Marrow CD34 Cells+, 500,000 cells, cryopreserved, isolated from mononuclear cells using positive immunomagnetic selection
Sales unit: each -
CompareHuman Bone Marrow CD34+ Progenitor Cells, Cryopreserved, 300,000Catalog #: 2M-101A
Bone Marrow CD34+ Cells, 300,000 cells, cryopreserved, positively selected
Sales unit: each -
CompareHuman Peripheral Blood Mononuclear Cells (hPBMC), Cryopreserved, 50 million, w/cell population frequencyCatalog #: CC-2702P
Cryopreserved ampule of Human Peripheral Blood Mononuclear Cells (hPBMC) containing ≥ 50 million cells with cell population frequency information
Sales unit: Ampule -
CompareTheraPEAK® P3 Primary Cell Nucleofector® Solution Set (126 mL + 28 mL)Catalog #: G4LP3-126000
For use in combination with TheraPEAK® Nucleocuvette® Cartridges, supporting the use of the 4D-Nucleofector® LV Unit in a GMP environment.
Sales unit: items -
Compare4D-Nucleofector® LV Unit PROCatalog #: AAF-1003L
Next generation large-scale Nucleofector® Platform for closed, scalable transfection of up to 1 billion cells – from research to GMP manufacturing
Sales unit: each
-
References - X-Vivo™Overview of relevant references
-
Primary Normal Human Cells and MediaIn Vivo Relevance. In Vitro Results. Updated and revised cell content.
-
X-VIVO Reference Guide 2025A curated list of peer-reviewed articles related to X-VIVO RUO media as used for culturing different primary cells and is a resource for potential consumers to find scientific data.
-
Building Better In Vitro Models Using the Quasi Vivo® SystemOverview webinar providing details and application data using the Quasi Vivo® Systems delivered by Dr. Kelly Davidge, Scientist at Kirkstall Inc. -
Terms and Conditions TheraPEAK® T-VIVO® Sample Request ProgramTerms and Conditions TheraPEAK® T-VIVO® Sample Requests
-
Instructions for Use – TheraPEAK® X-VIVO® Cell Culture MediumInstructions for how to use the X-VIVO® Media Series
-
TheraPEAK® T-VIVO® Cell Culture Medium – OverviewView or download this document for a comprehensive overview and learn how the chemically defined TheraPEAK® T-VIVO® Medium enhances T-cell culture and accelerates therapy development.
-
TheraPEAK® X-VIVO® Hematopoietic Cell Culture MediumSerum-free, GMP produced medium for cell therapy applications
-
Non-viral Gene Modification for Ex-vivo Cell TherapyIn this interview our Director Transfection R&D discusses the advantages of non-viral transfection technologies for CRISPR- or transposon-based genetic modification cell and gene therapy.
-
A Novel In Vitro Liver Cell Culture Flow System Allowing Long-Term Metabolism and Hepatotoxicity Studies]Manuscript published in Applied In Vitro Toxicology journal describes improvement of CYP450 phenotype of primary cryopreserved hepatocytes using Quasi Vivo® System